Module 2 appears to be more cancer-specific as it is consistently enriched for cell cycle pathways (“Cell cycle,” “Cellular senescence”), known cancer-related signaling pathways (“mTOR” and “JAK-STAT” signaling pathways), metabolic pathways, and cancer-specific disease terms (Supplementary Fig. S11). Here, MTOR is linked to cancer.